Huntington's disease trials in China

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  Where

  Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Wuhan

  Age

  21 years to 70 years

  People

  770 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07326709 · EU 2025-522227-99-00
• No phaseTaking people
  Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease

  Where

  Fuzhou

  Age

  18 years to 75 years

  People

  24

  Run by

  First Affiliated Hospital of Fujian Medical University

  See details and how to joinNCT07513844